For decades, the clinical approach to obesity was defined by a frustratingly simple metric: the Body Mass Index (BMI). Patients were often told to “eat less … Read more
For many people using the new generation of GLP-1 receptor agonists to treat obesity, the primary fear isn’t the initial weight loss—it is the inevitable regain. … Read more
For millions of Americans living with obesity, the arrival of GLP-1 receptor agonists has felt like a medical turning point. These medications—including household names like Wegovy … Read more
For millions of people, the hardest part of weight loss isn’t the initial climb—it is the plateau that follows. The psychological and physiological battle to keep … Read more
For years, the conversation surrounding ultra-processed foods has centered primarily on weight gain and metabolic diseases like diabetes. However, new evidence suggests that the impact of … Read more
For many living with eating disorders, a restaurant menu can feel like a minefield. The simple act of choosing a meal often triggers a complex internal … Read more
For decades, the switch from sugar to diet alternatives has been marketed as a simple mathematical trade-off: enjoy the sweetness without the calories. Still, emerging research … Read more
For decades, cancer was largely viewed as a disease of aging—a biological inevitability that arrived in the later chapters of life. But a troubling shift is … Read more
The way we define obesity is undergoing a critical re-evaluation, and it’s a debate that extends far beyond the familiar metric of the Body Mass Index … Read more
Nearly half of U.S. Adults—around 113 million people—are living with diabetes or prediabetes, a condition contributing to an estimated $412.9 billion in annual healthcare costs, according … Read more
